Welcome to Cell & Gene Therapy
Rx-360 Member companies working together to share best practices on how we approach cell and gene therapy suppliers while still in the clinical phase.
If you are interested in joining this Working Group please contact Michael Cavacini (email@example.com).
Rx-360 Guidance and Best Practices for Raw Material Supply Chain Security for Cell and Gene Therapies
Cell and gene therapies (CGT) are novel therapeutic modalities with greater than one thousand clinical trials ongoing globally. The unmet need for treatment options and the promise of these therapies has prompted regulatory agencies world-wide […]